Spex Capital

Knokcare is an app-based healthcare platform designed to streamline the connection between patients and medical professionals. It offers a comprehensive solution that includes AI chatbots for self-assessment, video consultations, and in-home doctor visits, all integrated within a single application. This approach enhances patient convenience and improves the efficiency of healthcare systems. The platform also ensures the security of patient records, allowing medical institutions and healthcare providers to deliver effective care. If a patient's condition is deemed serious, Knokcare facilitates a referral to a hospital for further treatment.

Skin Analytics, established in 2012 and headquartered in London, specializes in online healthcare services focused on skin health. The company uses smartphone photography and proprietary algorithms to transform images into valuable data, aiding dermatologists in diagnosis and treatment decisions. By building a digital history of the skin, Skin Analytics empowers individuals and healthcare professionals to monitor, track, and understand skin conditions, ultimately improving skin health. The company's patent-pending technology enables early detection of melanoma and other skin cancers, as well as precancerous lesions, with a focus on delivering a range of consumer and clinical skin health products over the next three years.

Log my Care is a provider of a free electronic care planning and management system aimed at enhancing coordination and communication within care facilities. The platform replaces traditional paper recording with an electronic system, featuring a shared to-do log that informs care employees of their assigned tasks. Additionally, it offers printable reports on activity performance, allowing managers to maintain oversight of their operations efficiently. This software facilitates better management of care services, ensuring that providers can operate more effectively while delivering quality care to clients.

MediShout Ltd. is a London-based company that develops a digital platform aimed at enhancing operational efficiency within healthcare settings such as hospitals, general practices, and care homes. Established in 2013, the platform connects healthcare teams, suppliers, and various systems, facilitating better communication and workflow among staff. By integrating features like two-way conversations, instant feedback, and artificial intelligence, MediShout addresses inefficiencies in hospital environments, helping to streamline processes and predict future challenges. The technology aims to reduce delays in patient care and optimize resource utilization, allowing healthcare professionals to focus more on patient needs and less on administrative burdens.

Firza Ltd specializes in providing tailored support and operational assistance to the healthcare sector, including general practices, community pharmacies, prisons, and care homes. The company offers a comprehensive range of services such as medication reviews, prescription reauthorizations, document management, and out-of-hours support. Additionally, Firza facilitates care home assistance, flexible general practice hours, pharmacist-led clinics, and quality improvement initiatives. Utilizing technology-enabled workforce solutions, Firza incorporates robotic process automation and artificial intelligence to enhance primary healthcare operations. Founded in 2014 and based in London, Firza is committed to delivering practical solutions that cater to the specific needs of healthcare providers, thereby modernizing the delivery of primary health care services across the United Kingdom.

LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

Skin Analytics, established in 2012 and headquartered in London, specializes in online healthcare services focused on skin health. The company uses smartphone photography and proprietary algorithms to transform images into valuable data, aiding dermatologists in diagnosis and treatment decisions. By building a digital history of the skin, Skin Analytics empowers individuals and healthcare professionals to monitor, track, and understand skin conditions, ultimately improving skin health. The company's patent-pending technology enables early detection of melanoma and other skin cancers, as well as precancerous lesions, with a focus on delivering a range of consumer and clinical skin health products over the next three years.